Data Registry Following Patients Using Supera Stent in the Femoral Arteries

Exclusion Criteria: (Clinical) * Patient or legal guardian understands registry procedures and has voluntarily signed an informed consent in accordance with institutional and local regulatory policies. (Note: Retrospective data may be collected and entered into the EDC system after a fully executed informed consent has been provided). * Rutherford-Becker classification 2 through 5 only * Patient is at least 18 years of age and of legal age of consent. * Patient must be willing to participate in the registry for at least 5 years. (Angiographic) * Target lesion is a single de novo or restenotic (outside a stent) SFA or Popliteal artery lesion ≥ 1 cm from origin of another stent; additional lesions may be present., but there is only one target lesion * All SFA target lesions are to be located with the proximal point at least 2 cm below the origin of the profunda femoris artery. * All Popliteal Artery target lesions are to be located with the most distal point at least 1 cm proximal to the bifurcation of the anterior tibial artery and the tibioperoneal trunk. * Target lesion length 1-20 cm (visual estimate) * Target lesion stenosis ≥50% (visual estimate) * Popliteal artery patent if the lesion is in the SFA * SFA patent if the lesion is in the popliteal artery * At least one widely patent (\< 50% stenosis) infrapopliteal artery (for distal run-off) Exclusion Criteria: (Clinical) * Evidence of heparin induced thrombocytopenia (HIT), or intravenous tPA, Plavix, Ticlid, or as…